Mass spectrometry-based metabolomics uncovers distinct metabolic signatures and potential therapeutic targets in Plasmodium knowlesi

Uthailak, N; Chotirat, S; Anatjitsupha, A; Thongyod, W; Tipthara, P; Sattabongkot, J; Tarning, J; Nguitragool, W; Reamtong, O

Journal article

Mass spectrometry-based metabolomics uncovers distinct metabolic signatures and potential therapeutic targets in Plasmodium knowlesi

Abstract:: Malaria remains a major global health challenge, caused by several Plasmodium species and transmitted via mosquito vectors. Among these, Plasmodium knowlesi is notable for its zoonotic nature, capable of infecting both macaques and humans. The incidence of P. knowlesi infections has been rising, particularly in Southeast Asia, raising public health concerns. However, compared to other Plasmodium species, the biology, pathophysiology, and transmission dynamics of P. knowlesi remain poorly understood. Given the absence of a licensed vaccine and the increasing threat of drug resistance, a deeper understanding of P. knowlesi biology is essential for effective control and management strategies. This study investigates the metabolomic landscape of P. knowlesi across three intraerythrocytic stagesring, trophozoite, and schizont using mass spectrometry-based metabolomics to gain insights into parasite biology. The analysis revealed distinct metabolic profiles, particularly in the ring stage compared to the other two stages. While glycerophospholipid metabolism and sphingolipid de novo biosynthesis emerged as key pathways associated with common metabolites across all stages, phosphatidylserine synthesis was specifically linked to ring-stage-biased metabolites. Notably, CDP-diacylglycerol-inositol 3-phosphatidyltransferase was highlighted as a promising target based on shared and stage-biased metabolites. Collectively, our findings offer a comprehensive metabolomic profile of P. knowlesi blood-stage development, enhancing our understanding of its biology and identifying potential drug targets that could support the development of novel therapeutic strategies against P. knowlesi malaria.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Uthailak, N., Chotirat, S., Anatjitsupha, A., Thongyod, W., Tipthara, P., Sattabongkot, J., Tarning, J., Nguitragool, W., & Reamtong, O. (2025). Mass spectrometry-based metabolomics uncovers distinct metabolic signatures and potential therapeutic targets in Plasmodium knowlesi. PLoS ONE, 20(11).

MLA Style

Uthailak, N, et al. “Mass Spectrometry-Based Metabolomics Uncovers Distinct Metabolic Signatures and Potential Therapeutic Targets in Plasmodium Knowlesi.” PLoS ONE, vol. 20, no. 11, 2025.

Chicago Style

Uthailak, N, S Chotirat, A Anatjitsupha, et al. 2025. “Mass Spectrometry-Based Metabolomics Uncovers Distinct Metabolic Signatures and Potential Therapeutic Targets in Plasmodium Knowlesi.” PLoS ONE 20 (11).
Print